Norden Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Buy
5,184
+1,439
+38% +$78.1K 0.02% 635
2026
Q1
$235K Sell
3,745
-9,474
-72% -$758K 0.02% 534
2025
Q4
$1.26M Sell
13,219
-2,038
-13% -$200K 0.12% 149
2025
Q3
$1.49M Buy
15,257
+12,443
+442% +$1.29M 0.15% 135
2025
Q2
$302K Buy
+2,814
New +$285K 0.03% 445

Other funds holding BSX

Norden Group's BSX Position: Q2 2026 in Review

Norden Group increased its Boston Scientific (BSX) stake by 38% in Q2 2026, buying an estimated $78.1K and bringing the position to 5,184 shares worth $221K. The position accounts for 0.02% of the portfolio, ranked #635.

Norden Group first reported a position in BSX in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.49M in Q3 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Norden Group held 5,184 shares of Boston Scientific worth $221K as of Q2 2026.
  • Norden Group bought 1,439 Boston Scientific shares in Q2 2026, an estimated $78.1K.
  • Boston Scientific made up 0.02% of Norden Group's portfolio in Q2 2026, its #635 holding.
  • Norden Group first reported a position in Boston Scientific in Q2 2025 and has held it in 5 quarters since.
  • Norden Group's Boston Scientific position peaked at $1.49M in Q3 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.